| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 08/15/2002 | WO2002062975A2 Regulation of human elongase hselo1-like protein |
| 08/15/2002 | WO2002062974A2 Regulation of human elongase hselo1-like protein |
| 08/15/2002 | WO2002062973A2 Lipase variants |
| 08/15/2002 | WO2002062964A2 Ap1 amine oxidase variants |
| 08/15/2002 | WO2002062962A2 60491, a novel human acyltransferase family member and uses thereof |
| 08/15/2002 | WO2002062948A2 25828, a novel human aminopeptidase and uses therefor |
| 08/15/2002 | WO2002062837A2 Cells with enhanced pkr expression for increasing cytokine production |
| 08/15/2002 | WO2002062827A2 Improved protein disaggregation and refolding using high pressure |
| 08/15/2002 | WO2002062825A2 Detection of polymorphisms in the human 5-lipoxygenase gene |
| 08/15/2002 | WO2002062820A2 Haplotypes of the cyp27b1 gene |
| 08/15/2002 | WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/15/2002 | WO2002062370A2 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins |
| 08/15/2002 | WO2002062369A2 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer |
| 08/15/2002 | WO2002062135A2 Scce modified transgenic mammals and their use as models of human disease |
| 08/15/2002 | WO2002062134A1 Human sphingosine-1-phosphate phosphatase |
| 08/15/2002 | WO2002042429A3 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 08/15/2002 | WO2002042244A3 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds |
| 08/15/2002 | WO2002020732A3 Regulation of human map kinase phosphatase-like enzyme |
| 08/15/2002 | WO2002018554A3 Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof |
| 08/15/2002 | WO2002018369A3 Peptidomimetic protease inhibitors |
| 08/15/2002 | WO2002013763A3 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 08/15/2002 | WO2002002760A3 25869, a human carboxylesterase and uses thereof |
| 08/15/2002 | WO2002002050A3 Prevention and treatment of mycoplasma-associated diseases |
| 08/15/2002 | WO2001098466A3 Regulation of human prostasin-like serine protease |
| 08/15/2002 | WO2001090319A3 Fructosyltransferases (inulosucrase and levansucrase) from lactobacillus reuteri |
| 08/15/2002 | WO2001085968A9 Production of conjugated linoleic and linolenic acids in plants |
| 08/15/2002 | WO2001066713A8 Activation of pure prothrombin to thrombin with sodium citrate |
| 08/15/2002 | WO2001064899A3 Nucleotide sequences encoding proteins that take part in the biosynthesis of l-serine, improved method for microbially producing l-serine, and genetically modified microorganism suitable for use in said method |
| 08/15/2002 | WO2001040260A9 Method of producing and purifying angiostatin |
| 08/15/2002 | WO2001029232A9 Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage |
| 08/15/2002 | US20020112261 Transformation of monocotyledoneous plants using Agrobacterium |
| 08/15/2002 | US20020112258 Methods of using viral replicase polynucleotides and polypeptides |
| 08/15/2002 | US20020112255 Transgenic mice containing intestinal alkaline phosphatase gene disruptions |
| 08/15/2002 | US20020112253 Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action |
| 08/15/2002 | US20020112251 Nuclelotide sequences for use in the treatment proliferative defects |
| 08/15/2002 | US20020111469 Polypeptide for use in the treatment of tumors, lung defects, inflammation and heart defects |
| 08/15/2002 | US20020111313 Tripeptide dosage |
| 08/15/2002 | US20020111310 25219, a novel human aminotransferase and uses therefor |
| 08/15/2002 | US20020111307 46508, a novel human peptidyl-tRNA hydrolase family member and uses thereof |
| 08/15/2002 | US20020111289 Genetic engineering; cancer diagnosis |
| 08/15/2002 | US20020110908 Novel human kinases and polynucleotides encoding the same |
| 08/15/2002 | US20020110897 Nucleotide squences coding preferential operon for use in the generation of an antibiotics and desoamine |
| 08/15/2002 | US20020110895 Nucleotide sequences coding enzymatic polypeptide for use in treatment of thrombosis and in the immune defects |
| 08/15/2002 | US20020110894 Nucleic acids encoding zinc metalloproteases |
| 08/15/2002 | US20020110892 Human RNase H and compositions and uses thereof |
| 08/15/2002 | US20020110891 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of allergies, cancer, infections, graftrejection and autoimmune diseases |
| 08/15/2002 | US20020110890 Expression vector for use in the monitoring of cyclic adenosine monophosphate concentration |
| 08/15/2002 | US20020110889 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/15/2002 | US20020110888 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/15/2002 | US20020110885 Methanotrophic carbon metabolism pathway genes and enzymes |
| 08/15/2002 | US20020110884 Polypeptides controlling phytate metabolism in plants |
| 08/15/2002 | US20020110883 Novel motor proteins and methods for their use |
| 08/15/2002 | US20020110879 Nucleotide sequences coding for the ppgK gene |
| 08/15/2002 | US20020110878 Nucleotide sequences which code for the metY gene |
| 08/15/2002 | US20020110877 Nucleotide sequences which code for the metE gene |
| 08/15/2002 | US20020110876 Method for producing threonine and isoleucine |
| 08/15/2002 | US20020110874 Recombinant production of novel polyketides |
| 08/15/2002 | US20020110863 Nucleotide sequences coding enzymatic polypeptide for use as tool genetic engineering |
| 08/15/2002 | US20020110859 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/15/2002 | US20020110854 Culture product; genetic engineering; baking, detergents |
| 08/15/2002 | US20020110811 Variants of protein kinases |
| 08/15/2002 | US20020110802 Expression vector for use as a tool for the generation of exogenous proteins |
| 08/15/2002 | US20020110559 Confering an immune response to a tumor cell in a mammal by administering antibody which binds to aspartyl (asparaginyl) beta hydroxylase (HAAH) |
| 08/15/2002 | US20020110550 Using esterase activity enzyme selected from pepper esterase and porcine esterase for protection of plant against phytopathogenic fuigi, protects plant against phytopathogenic fungi by inhibition of fungal appressorium formation |
| 08/15/2002 | US20020110548 Human GDP-mannose 4,6 dehydratase |
| 08/15/2002 | US20020110546 Implanting cells of an immortalized human neuro-derived fetal cell line into the host for therapy |
| 08/15/2002 | US20020109607 Spread spectrum meter reading system utilizing low-speed/high-power frequency hopping |
| 08/15/2002 | CA2796391A1 Myeloperoxidase, a risk indicator for cardiovascular disease |
| 08/15/2002 | CA2437577A1 Human sphingosine-1-phosphate phosphatase |
| 08/15/2002 | CA2437461A1 Human phospholipase b-like polypeptide and uses thereof |
| 08/15/2002 | CA2437423A1 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 08/15/2002 | CA2437189A1 Ap1 amine oxidase variants |
| 08/15/2002 | CA2436746A1 Charge tags and the separation of nucleic acid molecules |
| 08/15/2002 | CA2435835A1 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer |
| 08/15/2002 | CA2434045A1 Improved protein disaggregation and refolding using high pressure |
| 08/14/2002 | EP1231277A2 Biocompatible implant for in vivo formation of a neo-organ |
| 08/14/2002 | EP1231274A2 Modified porteinase inhibitors |
| 08/14/2002 | EP1231273A1 Terpene synthase/cyclase and olefin synthase and uses thereof |
| 08/14/2002 | EP1231272A2 Procedure for obtaining bovine chymosin (rennin), curd |
| 08/14/2002 | EP1231269A1 Methods and compositions for polypeptide engineering |
| 08/14/2002 | EP1231266A1 Arabidopsis-origin gdp-4-keto-6-deoxy-d-mannose-3,5-epimerase-4-reductase gene |
| 08/14/2002 | EP1231265A2 A receptor protein tyrosine kinase |
| 08/14/2002 | EP1231264A1 New protein |
| 08/14/2002 | EP1231261A2 A method for isolating cells that express FLK-1 receptors on their surface |
| 08/14/2002 | EP1231260A2 A method for isolating cells that express FLK-2 receptors on their surface |
| 08/14/2002 | EP1231213A1 Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields |
| 08/14/2002 | EP1230933A1 Remedies for intractable wound |
| 08/14/2002 | EP1230374A2 Modification of polysaccharide containing materials |
| 08/14/2002 | EP1230373A1 Use of a class of enzymes and their encoding genes to increase the oil content in transgenic organisms |
| 08/14/2002 | EP1230372A2 SUNFLOWER RhoGAP, LOX, ADH, AND SCIP-1 POLYNUCLEOTIDES AND METHODS OF USE |
| 08/14/2002 | EP1230366A2 Human atpases and polynucleotides encoding the same |
| 08/14/2002 | EP1230364A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 08/14/2002 | EP1230363A2 Educational kit and method using colipase-like protein-1 |
| 08/14/2002 | EP1230352A2 Inhibitors of vegetable cystathionin gamma synthase |
| 08/14/2002 | EP1230351A1 Fungamyl-like alpha-amylase variants |
| 08/14/2002 | EP1230350A1 Site-directed mutagenesis of escherichia coli phytase |
| 08/14/2002 | EP1230349A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 08/14/2002 | EP1230348A1 Microtiter plate (mtp) based high throughput screening (hts) assays |
| 08/14/2002 | EP1230343A2 Aspegillus niger beta-glucosidase gene, protein and uses thereof |
| 08/14/2002 | EP1230341A1 Geranyl diphosphate synthase large subunit, and methods of use |